Harold L Atkins (Harold Atkins)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Ejection Fraction

Patient Reported

Top Venues

Current oncology (Toronto, Ont.)

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Neurology(R) neuroimmunology & neuroinflammation

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Anubhav Agarwal, Natasha Kekre, Harold L Atkins, Haris Imsirovic, Brian Hutton, Doug Coyle, Walter P Wodchis
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive Study. Current oncology (Toronto, Ont.) 31 (8) (2024)
Anubhav Agarwal, Natasha Kekre, Harold L Atkins, Haris Imsirovic, Brian Hutton, Doug Coyle, Walter P Wodchis
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive Study. Current oncology (Toronto, Ont.) 31 (8) (2024)
Anubhav Agarwal, Natasha Kekre, Harold L Atkins, Haris Imsirovic, Brian Hutton, Doug Coyle, Walter P Wodchis
Phase-Based and Lifetime Health System Costs of Care for Patients Diagnosed with Leukemia and Lymphoma: A Population-Based Descriptive Study. Current oncology (Toronto, Ont.) 31 (8) (2024)
Simon Thebault, Hailey Bergman, Harold L Atkins, Mark S Freedman, John Brooks
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent. Neurology(R) neuroimmunology & neuroinflammation 10 (1) (2022)
Mackenzie Wilson, Walter P Wodchis, Terry Hawrysh, Ian D Graham, Harold L Atkins, Natasha Kekre, Doug Coyle, Manoj M Lalu, Dean A Fergusson, Kelvin K W Chan, Daniel A Ollendorf, Justin Presseau
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience. PharmacoEconomics 40 (11) (2022)
Harold L Atkins, Mark S Freedman
Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 14 (4) (2018)